This report illustrates how Forbion and its portfolio companies are contributing to better health outcomes and environmental resilience. From therapeutic breakthroughs to sustainable biotechnology advances through our BioEconomy strategy, the stories and data across these pages show how science, purpose, and partnership come together to create lasting value for not only patients but the world around us.

In 2025 we reinforced our core purpose of addressing human and planetary health. We achieved this by supporting scientific innovation that significantly improves the lives of patients and contributes to a healthier planet. We witnessed meaningful progress across our portfolio with significant progress in treatments for people living with serious and underserved conditions.

Embracing our values

Our work is guided by our values of Transparency, Entrepreneurial Mindset, Equal Opportunity, Sustainable Excellence, and Collaboration. These values define who we are and our aspirations to operate as a truly integrated global team. These principles ensure that as we grow, we continue to build an organization capable of long-term impact; one that prioritizes trust, integrity, and partnership in service of patients and our planet.

Simultaneously, our BioEconomy strategy strengthened our commitment to planetary health. By supporting sustainable biotechnologies and circular economy innovations, we are helping to build a more sustainable world.

The future

We continue to champion science with the potential to change lives and to help build a healthier, more sustainable future. As we continue to grow, we remain steadfast in our pursuit of implementing systems to monitor and further improve our impact reporting. In realizing this goal, we thank each and every employee, our portfolio companies, and last but not least, our investors for sharing this commitment.